Trial · NCT01995487
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Target Lesion Failure (TLF) | 12 months | percentage of TLF | NUMBER | |
| SECONDARY | Device Success | Determined at time of baseline procedure | |||
| SECONDARY | TLF | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Major Adverse Cardiac Events | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Target Vessel Failure | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | All Cause Mortality | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Cardiac Death | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Myocardial Infarction | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Target Vessel Related MI | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Ischemia Driven TLR | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Ischemia Driven TVR | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Stent Thrombosis | 30 days, 6 months, and 1, 2, 3, 4 and 5 years | |||
| SECONDARY | Angiographic Sub-Study: In-stent and In-segment Late Loss | 13 months | |||
| SECONDARY | IVUS Sub-Study: In-stent Percent Neointimal Hyperplasia | 13 months | |||
| SECONDARY | IVUS Sub-Study: Stent Mal-apposition | 13 months | |||
| SECONDARY | Lesion Success | Determined at time of baseline procedure | |||
| SECONDARY | Procedure Success | Determined at time of baseline procedure |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01995487/outcomes